Directions

Please refer to the medication’s patient information leaflet before starting any new medication.

Application: Once daily, apply a pea-sized amount to each of the five areas of the face: forehead, chin, nose, and each cheek.
Method: Spread the gel smoothly and evenly in a thin layer. Avoid eyes, lips, and mucous membranes.
Post-Application: Wash hands immediately after applying.
Storage: Store at room temperature (20°C to 25°C). Keep out of reach of children.

Mirvaso 3 mg/g Gel is a targeted topical treatment developed for adults suffering from persistent facial redness associated with rosacea. This redness is often caused by overactive or dilated blood vessels in the skin, and it can be difficult to manage with conventional skincare alone. Mirvaso offers an advanced, prescription-strength option that directly addresses this vascular component of rosacea. By applying a small amount of gel daily, users may experience visible and sustained reduction in facial redness, improving both comfort and confidence throughout the day.

Persistent redness is a common and distressing symptom for those with rosacea, often triggered by environmental factors, heat, stress, or spicy foods. While rosacea cannot be cured, Mirvaso helps to significantly control one of its most visible and frustrating effects. It is suitable for use as part of a broader rosacea management plan, alongside oral or topical medications and gentle skincare regimens.

How It Works

Mirvaso contains the active ingredient brimonidine tartrate, an alpha-2 adrenergic receptor agonist. When applied to the skin, brimonidine causes vasoconstriction, or narrowing of the blood vessels in the superficial layers of the skin. This reduces the excess blood flow that causes persistent facial redness. The effects of the gel typically become noticeable within 30 minutes of application and can last for up to 12 hours. Because of its rapid onset and long duration, Mirvaso is an ideal daily-use product for people who want to manage their rosacea-related redness effectively and discreetly.

Unlike general anti-inflammatory creams or cosmetic products, Mirvaso specifically targets the vascular component of rosacea. It does not treat pimples, bumps, or pustules associated with other rosacea subtypes, but it plays a key role in a comprehensive management strategy for individuals with visible erythema.

Why Choose Mirvaso

Targeted Redness Control: Designed specifically to reduce persistent facial redness caused by rosacea.
Fast-Acting Relief: Noticeable improvement can occur in as little as 30 minutes after application.
Long-Lasting Results: Effects may last up to 12 hours, offering day-long confidence and relief.
Easy to Use: Simple once-daily application that fits easily into a morning routine.
Compatible With Makeup: Can be used under makeup once the gel has dried, without affecting its efficacy.

Important Note

Mirvaso should only be used on the face and must not be applied to damaged or irritated skin, open wounds, or mucous membranes. It is important to avoid the eye area and to wash hands thoroughly after application. Although the treatment provides temporary control of redness, it is not a cure for rosacea and should be used consistently to maintain results. Some users may experience rebound redness or worsening of symptoms; discontinue use and consult your doctor if this occurs. This medicine is for adults only and should not be used by individuals under the age of 18.